HOME >> BIOLOGY >> NEWS
Nanotechnology's progress and challenges addressed during ACS meeting

EACH PAPER EMBARGOED FOR RELEASE UNTIL DATE AND TIME OF PRESENTATION UNLESS NOTED OTHERWISE

SAN DIEGO From promising diagnostic tests to tomorrow's electronics, nanotechnology the science and technology of the ultra-small is getting bigger all the time. More than 60 presentations, in symposia ranging from medicine to the environment to business, highlight nanotechnology's progress and challenges during the 229th national meeting of the American Chemical Society, the world's largest scientific society, in San Diego, March 13-17. Highlights from selected symposia and research presentations are highlighted below:

Monday, March 14

How do you name a nanomaterial?When the field of molecular genetics emerged, scientists often found themselves calling a new gene by different names. Nanotechnology researchers now face a similar challenge. What's more, this name game has regulatory importance: Today, the government evaluates and regulates the toxicity of a named chemical entity without considering different-sized versions of it. But nanoparticles bear unique electronic and mechanical features. Now, to clear up these concerns and more, a researcher at Rice University is leading the call to build a nomenclature for nanotechnology. (IEC 116, Monday, March 14, 4:00 p.m., Hyatt Regency, Room Ford A, during the symposium "Nanotechnology and the Environment.")

Growing the business of nanotechnology Since nanotechnology emerged, dozens of businesses in California have launched big dreams for tiny tools. Illustrating this boom is Nanosys, launched in 2002 in Palo Alto, Calif. Nanosys has built early versions of nano-enabled solar cells, flexible electronics, and nano chips for drug discovery research. Along the way, the company has formed strategic relationships with industry giants such as Intel, Dupont, In-Q-Tel, SAIC, Sharp, and Matsushita. T
'"/>


17-Mar-2005


Page: 1 2 3

Related biology news :

1. Nanotechnologys past, present and future: A Congressional perspective
2. Study begins to reveal clues to the cause and progression of sepsis
3. ACMG recognizes progress made in newborn screening
4. Neuroblastoma expert reviews progress and challenges in fighting difficult pediatric cancer
5. Scripps research scientists show protein accelerates breast cancer progression in animal models
6. Inflammation is at the origin and progression of diseases such as diabetes or cancer
7. Los Alamos National Laboratory making progress in Groundwater Protection Program
8. Crucial progress in understanding Fragile X mental retardation protein
9. Yin and yang -- Balance could play key role in progression of Alzheimers disease
10. Cancer scientists create human leukemia process to map how disease begins, progresses
11. Treatment-induced growth factor causes cancer progression

Post Your Comments:
(Date:2/24/2015)... This report analyzes the worldwide markets for Face and ... and Voice Biometrics. The report provides separate comprehensive analytics for the ... Europe , Asia-Pacific , ... and Latin America . Annual estimates and forecasts ... historic analysis is provided for these markets. Market data and analytics ...
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
(Date:3/4/2015)... Proove Biosciences , a commercial ... to announce the launch of their CME-accredited course ... of Pain”. , The continuing medical education program ... year. The focus of the program is to ... treatments, integrate appropriate pain management techniques, and incorporate ...
(Date:3/4/2015)... 2015 Vegalab announced the acquisition of Ecowin, ... year. As part of the acquisition, Ecowin rebranded itself ... his role as CEO for the company,s Korea operations. ... work alongside Koo and oversee developments at the new ... Koo founded Ecowin in 2008 to ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
(Date:3/3/2015)... , March 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... 2015 Global Healthcare Conference in Miami, FL ... PT. David A. Ramsay , Chief Financial Officer, will ... webcast through the "Investors" section of Halozyme,s corporate website at ... for 90 days following the event. To access the live ...
Breaking Biology Technology:Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2
Cached News: